# MASLD: time to optimise regional research priorities

**Authors:** The Lancet Regional Health – Southeast Asia

PMC · DOI: 10.1016/j.lansea.2026.100732 · The Lancet Regional Health - Southeast Asia · 2026-02-19

## Full-text entities

- **Genes:** TM6SF2 (transmembrane 6 superfamily member 2) [NCBI Gene 53345], PNPLA3 (patatin like domain 3, 1-acylglycerol-3-phosphate O-acyltransferase) [NCBI Gene 80339] {aka ADPN, C22orf20, iPLA(2)epsilon}
- **Diseases:** NCDs (MESH:D000073296), obesity (MESH:D009765), MASH (MESH:D005234), excess visceral adiposity (MESH:D007418), metabolic disease (MESH:D008659), death (MESH:D003643), Fibrosis (MESH:D005355), cardiometabolic diseases (MESH:D024821), inflammatory (MESH:D007249), MASLD (MESH:D008107), insulin resistance (MESH:D007333), Diabetes (MESH:D003920), NAFLD (MESH:D065626)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12931381/full.md

---
Source: https://tomesphere.com/paper/PMC12931381